SLC2A1 and cancer: The correlation between SLC2A1 expression and eight immune checkpoints (CTLA4, PDCD1, TIGIT, LAG3, CD274, HAVCR2, PDCD1LG2, and SIGLEC15) was further investigated across multiple cancer types.